Prostaglandin E1 responsive ductus at 11 months of age
Related Experiment Videos
Pediatric Cardiology
|January 1, 1984
Insights
A baby with heart failure and a patent ductus arteriosus (PDA) did not respond to indomethacin treatment. Surgical ligation was ultimately required for PDA closure.
Area of Science:
- Pediatric Cardiology
- Neonatal Physiology
- Congenital Heart Disease
Background:
- Patent ductus arteriosus (PDA) is a common congenital heart defect.
- Congestive heart failure in infants can be caused by unrepaired PDAs.
- Management of PDA often involves medical or surgical interventions.
Observation:
- An 11-month-old infant presented with congestive heart failure.
- The infant had an intermittently closing patent ductus arteriosus (PDA).
- Cardiac catheterization revealed PDA responsiveness to prostaglandin E1.
Findings:
- Indomethacin, a common treatment for PDA, failed to achieve permanent closure.
- The infant's PDA required surgical intervention.
- Prostaglandin E1 demonstrated temporary vasodilatory effects on the PDA.
Implications:
- This case highlights the limitations of indomethacin in certain PDA cases.
- Surgical ligation remains a definitive treatment option for refractory PDAs.
- Understanding PDA physiology is crucial for appropriate infant cardiac care.
Abstract:
An 11-month-old boy with congestive heart failure and an intermittently closing patent ductus arteriosus (PDA) is presented. During cardiac catheterization, the ductus proved responsive to prostaglandin E1. Permanent closure of the PDA could not be attained with indomethacin. The infant underwent surgical ligation of the PDA.